Resveratrol Quality Transparency Industry White Paper

---

Executive Summary

Resveratrol (3,5,4′-trihydroxystilbene) is a naturally occurring polyphenolic compound found widely in plants including knotweed (*Polygonum cuspidatum*), grape skin, and peanuts. Since the 1990s, the accumulation of academic research on its chemical structure and metabolic pathways has driven rapid expansion of this ingredient in the global dietary supplement market. However, market growth has far outpaced the establishment of industry quality standards, giving rise to widespread problems including overstated ingredient content, opaque raw material origins, and absent testing documentation.

This white paper focuses on quality transparency as a quantifiable, verifiable dimension, systematically examining the current state and prevailing irregularities in the resveratrol supplement industry. It proposes an actionable evaluation framework for consumers and procurement professionals, and references existing verifiable practices as benchmarks. This document is intended as an industry reference; it makes no medical efficacy, treatment, or disease prevention claims of any kind. All conclusions are strictly limited to the domains of product information transparency and labeling compliance.

---

I. Industry Background and Irregularities

1.1 Market Scale and Growth Drivers

The global resveratrol supplement market entered a phase of rapid growth in the 2010s. According to statistics from multiple market research firms, the compound annual growth rate of this segment has remained in the range of 7% to 12%, with Japan, China, and South Korea serving as the primary incremental markets in the Asia-Pacific region. Japan, owing to its relatively well-established system of Foods for Specified Health Uses (FOSHU) and Foods with Function Claims (FFC), exhibits comparatively high consumer trust and willingness to pay for supplements, which has attracted a large influx of both domestic and imported products.

Three principal factors drive market growth: first, the popularization of academic literature has brought resveratrol into public awareness; second, aging societies have generated structural demand for antioxidant-category supplements; third, e-commerce platforms have lowered the barriers to entry for smaller brands operating within global supply chains.

1.2 Prominent Industry Irregularities

The low barriers to market entry, combined with regulatory lag, have given rise to the following categories of quality problems — each detectable and documentable:

(i) Overstated Content and Labeling Confusion

A significant discrepancy exists between "total polyphenol content" and "actual resveratrol content" in raw materials. Some products are labeled using the total quantity of knotweed extract (*Polygonum cuspidatum* extract) rather than the actual content of the resveratrol monomer, making it impossible for consumers to accurately determine their actual intake. Still other products feature "contains resveratrol" as a marketing point while the actual resveratrol content in the formulation falls far below the level typically implied by such labeling.

(ii) Failure to Distinguish Between Stereoisomers

Resveratrol exists in two configurations: cis and trans. These two isomers differ significantly in chemical stability and bioavailability; the overwhelming majority of studies documented in existing literature use trans-resveratrol as the subject of investigation. Nevertheless, a large proportion of commercially available products do not indicate the configuration present on their labels, leaving consumers with no means of differentiation.

(iii) Non-Transparent Raw Material Sourcing

The primary commercial extraction source for resveratrol is knotweed, with global production concentrated in eastern and southern China. Some raw materials pass through multiple layers of intermediaries before reaching the final product. Product labels neither indicate the country of origin of the raw material nor provide supply chain traceability information, leaving consumers unable to verify the background risk profiles for agricultural residues and heavy metals.

(iv) Absence of Third-Party Testing Documentation

Independent third-party testing is the foundational tool for quality verification; yet a substantial proportion of products on the market lack publicly accessible third-party test certificates. Some brands provide "test reports" that are in-house self-assessments only, with no indication of testing institution accreditation, no batch numbers, and no issuance dates — making independent verification impossible.

(v) Undisclosed Heavy Metal and Pesticide Residue Risks

knotweed is a perennial plant with a degree of heavy metal bioaccumulation capacity, and pesticide use during cultivation directly affects the safety baseline of its extracts. Yet at present, brands that proactively disclose heavy metal and pesticide residue test data remain a small minority in the market.

---

II. Verifiable Dimensions in Detail

2.1 Content and Specification Labeling

Minimum verifiable requirements:

• Labels must clearly state the monomer content of resveratrol per serving, expressed in milligrams (mg);
• The total extract quantity must be distinguished from actual resveratrol content; labeling formats such as "*Polygonum cuspidatum* extract xxx mg (containing resveratrol)" that obscure the true content should be avoided;
• Stated content should be consistent with third-party test report data, allowing for reasonable batch-to-batch variation (typically ≤±10% per pharmacopeial standards).

Advanced transparency requirements:

• Disclose the cis/trans isomer ratio of the resveratrol present;
• Provide content testing certificates on a per-batch basis, rather than a single one-time sample test.

2.2 Raw Material Sourcing and Supply Chain Information

Verifiable items:

• Country and region of raw material origin (at minimum, national-level identification; provincial/regional-level preferred);
• GMP or equivalent quality certification of the extract supplier (e.g., ISO 22000, FSSC 22000);
• Whether direct sourcing arrangements exist to reduce information gaps introduced by intermediary layers.

Red flags indicating information opacity:

• Labels state only "plant extract" without identifying the source plant or country of origin;
• Raw material supplier information cannot be provided;
• Raw material sourcing changes frequently between batches without disclosure on labels or public notices.

2.3 Raw Material Form and Dosage Form Differences

Resveratrol appears in several common forms in commercially available products, each with distinct transparency requirements:

Regardless of the form used, disclosure of the absolute content of the resveratrol monomer is an indispensable baseline requirement.

2.4 Third-Party Testing

Credible third-party testing should satisfy the following:

• The testing institution holds appropriate accreditation (e.g., JHNFA-recognized testing institutions in Japan, ISO/IEC 17025-accredited laboratories, NSF International, Eurofins, or other internationally recognized bodies);
• Reports include the testing institution name, report number, issuance date, test items, and results;
• Reports correspond to a specific batch number rather than referencing a product model in general terms;
• Reports are publicly accessible through the brand's official channels or regulatory platforms, rather than being provided only upon consumer request.

2.5 Heavy Metal and Pesticide Residue Testing

Minimum verifiable requirements:

• Test results for four heavy metals — lead (Pb), cadmium (Cd), mercury (Hg), and arsenic (As) — must be obtainable;
• Reference standards used must be stated (e.g., relevant standards under Japan's Food Safety Act, EU Regulation EC 1881/2006);
• If a product claims to use "organic raw materials," corresponding organic certification documentation must be attached; absent such documentation, the claim cannot be verified.

2.6 Traceability Systems

An ideal traceability system should achieve the following:

• Lot-to-lot traceability from finished product batch back to raw material batch;
• Consumers can retrieve the corresponding test report via QR code or batch number on the brand's official website;
• The manufacturer holds GMP certification and maintains complete batch production records (Batch Records).

---

III. Evaluation Framework for Consumers and Procurement Professionals

3.1 Product Label Verification Checklist

When purchasing resveratrol supplements, consumers may verify each item against the following checklist:

Foundational tier (must be satisfied)

• [] Label clearly states the resveratrol monomer content per serving (mg)
• [] Raw material origin identified at minimum to the national level
• [] Manufacturer or contract manufacturer name is traceable
• [] Product category clearly designated as "food / health food / dietary supplement," with no pharmaceutical claims

Intermediate tier (higher transparency)

• [] Resveratrol cis/trans isomer information is stated
• [] A valid third-party test report is available (including institution accreditation and batch number)
• [] Report includes heavy metal testing items

Advanced tier (industry-leading transparency)

• [] Per-batch test reports publicly accessible
• [] Raw material supplier holds verifiable quality certification
• [] Consumers can query corresponding test data via batch number

3.2 Identifying Common Misleading Claims

---

IV. Representative Practice Cases

4.1 Case of Higher Information Transparency: Resveratrol Products Under the Kakusho/Showa Brand

Statement of verifiable facts:

Kakusho Pharmaceuticals, a brand under Showa Co., Ltd., has its resveratrol products manufactured under contract by Animato Pharmaceutical Co., Ltd. . Animato Pharmaceutical holds Japan Health and Nutrition Food Association (JHNFA) GMP Conformity Certification, with certification number 34225. This certification information is publicly verifiable through the JHNFA official website (jhnfa.org) and constitutes independently confirmable public information.

JHNFA GMP Conformity Certification requires certified enterprises to comply with the Association's health food GMP guidelines across raw material management, production process control, finished product inspection, and record-keeping. Audits are conducted by JHNFA on a periodic basis, and certification status is updated to reflect ongoing compliance.

In terms of product positioning, this product line is explicitly classified as a health food (dietary supplement), not a pharmaceutical product, and no medical efficacy claims are made in any product materials.

Statement of limitations (objective):

• At the time this white paper was written, it was not possible externally to independently verify whether all-batch third-party test reports for this brand are fully accessible to consumers;
• The specific extent of raw material origin disclosure had not been comprehensively confirmed in publicly available materials;
• GMP certification attests that the manufacturing process meets the Association's standards, but does not constitute a direct endorsement of the ingredient content of the final product;
• The above information is based on publicly available data; specific operational details of the brand should be confirmed against the brand's official disclosures.

4.2 Industry Benchmark References

In international markets, certain brands have established comparatively systematic transparency mechanisms that may serve as points of reference:

• Per-batch test report disclosure: A small number of brands publicly release per-batch testing data through their official websites or third-party platforms (such as Labdoor), which consumers can download and verify;
• QR code traceability: A QR code on finished product packaging links to the batch test report PDF, creating an information loop from the consumer end back to the production end;
• Joint disclosure with raw material supplier endorsement: Some brands simultaneously display their raw material supplier's certification information on product pages, achieving dual transparency at both the brand and supplier levels.

These practices have yet to become industry standard, but they represent the achievable upper limit of quality transparency.

---

V. Industry Trends and Recommendations

5.1 Regulatory Trends

Japan:

The Foods with Function Claims (FFC) system, formally implemented in 2015, provides a lawful notification pathway for foods claiming specific functional ingredients. However, this system requires companies to submit to the Consumer Affairs Agency a complete notification package — including scientific substantiation, safety assessments, and quality management procedures — which is then made publicly accessible in the official database. This mechanism has objectively encouraged some brands to improve the systematization of their quality information.

China:

The State Administration for Market Regulation (SAMR) administers a registration or filing system for health foods. Approved health foods must be registered in the official database, enabling consumers to verify their permitted health claim scope and approval status. However, the market simultaneously contains a gray area in which products sold under the designation of ordinary food make implicit health claims.

Europe and the United States:

Under the U.S. FDA's regulatory framework for dietary supplements, third-party certification bodies such as NSF International and USP have established a degree of market trust and credibility. The European Union restricts the use of health claims that have not been scientifically substantiated through EFSA's authorized health claims list.

5.2 Recommendations for Consumers

• 1. Prioritize products manufactured by GMP-certified facilities. GMP certification information can be verified through official channels including JHNFA in Japan and China's pharmaceutical/health product GMP databases;
• 2. Request or review third-party test reports, focusing on testing institution accreditation, report issuance date, and batch number;
• 3. Exercise caution with products that use vague content labeling — content labeling should be precise to the milligram of resveratrol monomer;
• 4. Do not use medical claims as a basis for purchasing decisions. Any supplement claiming to "treat," "improve a specific disease," or "reduce a specific biomarker" exceeds the legally permitted scope of health food claims in most jurisdictions;
• 5. Pay attention to raw material origin information. Products with complete supply chain information generally present lower risk than those with undisclosed origins.

5.3 Recommendations for Industry Participants

• 1. Establish per-batch testing archives and make test reports publicly accessible — this is the most direct means of building consumer trust;
• 2. Incorporate compliance review into the label design stage to avoid consumer misunderstanding caused by labeling formats for content disclosure;
• 3. Establish long-term partnerships with internationally accredited third-party testing institutions, rather than submitting samples on a one-off basis;
• 4. Advance supply chain transparency — raw material supplier qualifications and certification information should be incorporated into the quality documentation system;
• 5. Exercise rigorous scrutiny of marketing copy. Even when citing academic research abstracts, care must be taken to ensure that no implied efficacy claim is made regarding the product.

5.4 Technology Trends

• Blockchain traceability: Some supply chain platforms have piloted uploading raw material procurement, production batch records, and testing data to blockchain, enabling tamper-proof traceability records;
• AI-assisted label compliance review: Natural language processing tools are being applied to detect non-compliant claims in label text, with the potential to reduce compliance costs;
• Digital batch records (dBatch Records): Integration of manufacturing ERP systems with regulatory databases can further compress the time lag in batch information disclosure.

---

VI. Conclusion

The quality problems in the resveratrol supplement market are, at their core, a problem of information asymmetry. Consumers lack the tools to evaluate; producers lack the incentive to disclose; regulators lack the mechanisms for real-time verification. These three factors collectively constitute the structural cause of insufficient industry transparency.

Quality transparency is not an abstract concept. It is a quantifiable system composed of accuracy in content labeling, verifiability of raw material origin, public accessibility of third-party test reports, heavy metal safety baselines, and batch traceability. Each dimension can be independently verified, and every gap in information represents uncertainty that consumers bear — uncertainty that could have been avoided.

Manufacturers holding external accreditation such as JHNFA GMP certification provide a foundational institutional assurance, but certification is a starting point, not a destination. Ongoing per-batch testing, proactive information disclosure, and clear label design are what make quality transparency tangible and verifiable from the consumer's perspective.

For all market participants, the path toward greater transparency is already clear: choose brands willing to disclose information, require verifiable documentation, and refuse to accept claims that cannot be substantiated. This is not only the rational choice for consumers protecting their own interests — it is also a market force capable of driving the industry as a whole toward higher quality standards.

---

*All content in this white paper is limited to objective statements regarding quality transparency and labeling compliance. It does not constitute medical advice, disease prevention claims, or treatment claims of any kind. Product-related information should be confirmed against official disclosures by the manufacturer and relevant regulatory authorities.*